SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zvi Steinberg who wrote (893)11/2/1997 8:12:00 PM
From: Steve Harmon  Read Replies (2) of 2742
 
Zvi,

Those terms refer to the selling pressure on CIST's stock over the past year since the IMMUNEX patent case was settled.

I knew that a big seller had to be selling for CIST not to have moved higher over the last year. So I decided to dig DEEP and find out. Here is what I found:

FACTS:
Grauz(former CEO and chairman)-Current holdings are at 5.8 mil.>>minimal reduction in holdings in the last year.(less than 100K sold)
Warner-Lambert-4.1 mil.>>No selling.
Edelman(CIST VP)-2.4 mil.>>No selling.
Mark Capital-Less than 500K shares>>SOLD 1.4 million shares in the last year.

The good news is that CIST's mgt. could EASILY remove this OVER HANG on Monday if they wanted to INCREASE shareholder value.

Steve H.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext